{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T15:40:36Z","timestamp":1648654836183},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00120-008-1911-2","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T05:54:59Z","timestamp":1232430899000},"page":"79-87","source":"Crossref","is-referenced-by-count":0,"title":["Andrologische Testosteronersatztherapie"],"prefix":"10.1007","volume":"48","author":[{"given":"U.","family":"Paasch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-J.","family":"Glander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-U.","family":"Stolzenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,22]]},"reference":[{"key":"1911_CR1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2165\/00126839-200405060-00012","volume":"5","author":"Anonymous","year":"2004","unstructured":"Anonymous (2004) Testosterone undecanoate-Schering AG. Drugs R D 5: 368\u2013369","journal-title":"Drugs R D"},{"key":"1911_CR2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/CND.0b013e318176eb55","volume":"9","author":"Al-Harbi","year":"2008","unstructured":"Al-Harbi TM, Bainbridge LJ, McQueen MJ, Tarnopolsky MA (2008) Hypogonadism is common in men with myopathies. J Clin Neuromuscul Dis 9: 397\u2013401","journal-title":"J Clin Neuromuscul Dis"},{"key":"1911_CR3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/17425247.2.5.935","volume":"2","author":"Alberti","year":"2005","unstructured":"Alberti I, Grenier A, Kraus H, Carrara DN (2005) Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery. Expert Opin Drug Deliv 2: 935\u2013950","journal-title":"Expert Opin Drug Deliv"},{"key":"1911_CR4","first-page":"2008","volume":"Res","author":"az-Arjonilla","year":"2008","unstructured":"az-Arjonilla M, Schwarcz M, Swerdloff RS, Wang C (2008) Obesity, low testosterone levels and erectile dysfunction. Int J Impot Res: 2008 Oct 9 [Epub ahead of print]","journal-title":"Int J Impot"},{"key":"1911_CR5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13685530802169723","volume":"11","author":"Behre","year":"2008","unstructured":"Behre HM, Heinemann L, Morales A, Pexman-Fieth C (2008) Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men. Aging Male 11: 101\u2013106","journal-title":"Aging Male"},{"key":"1911_CR6","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/jcem.82.8.4163","volume":"82","author":"Behre","year":"1997","unstructured":"Behre HM, Kliesch S, Leifke E et al (1997) Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82: 2386\u20132390","journal-title":"J Clin Endocrinol Metab"},{"key":"1911_CR7","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00120-008-1798-y","volume":"47","author":"Beintker","year":"2008","unstructured":"Beintker M, Behre H (2008) Testosterone substitution with special regard to prostate cancer. Urologe A 47(12): 1588\u20131591","journal-title":"Urologe A"},{"key":"1911_CR8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2125.2005.02542.x","volume":"61","author":"Chik","year":"2006","unstructured":"Chik Z, Johnston A, Tucker AT et al (2006) Pharmacokinetics of a new testosterone transdermal delivery system, TDS-testosterone in healthy males. Br J Clin Pharmacol 61: 275\u2013279","journal-title":"Br J Clin Pharmacol"},{"key":"1911_CR9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2605.1980.tb00131.x","volume":"3","author":"Danner","year":"1980","unstructured":"Danner C, Frick J (1980) Androgen substitution with testosterone containing nasal drops. Int J Androl 3: 429\u2013435","journal-title":"Int J Androl"},{"key":"1911_CR10","doi-asserted-by":"crossref","first-page":"904","DOI":"10.4158\/EP.14.7.904","volume":"14","author":"Dobs","year":"2008","unstructured":"Dobs AS, Morgentaler A (2008) Does testosterone therapy increase the risk of prostate cancer? Endocr Pract 14: 904\u2013911","journal-title":"Endocr Pract"},{"key":"1911_CR11","first-page":"2008","volume":"Genet","author":"Dod\u00e9","year":"2008","unstructured":"Dod\u00e9 C, Hardelin JP (2008) Kallmann syndrome. Eur J Hum Genet: 2008 Nov 5 [Epub ahead of print]","journal-title":"Eur J Hum"},{"key":"1911_CR12","first-page":"90","volume":"1","author":"Emons","year":"2005","unstructured":"Emons G, Nieschlag E (2005) Hormone replacement therapy. Interview by Wiebke Kathmann. Dtsch Med Wochenschr Suppl 1: 90","journal-title":"Dtsch Med Wochenschr Suppl"},{"key":"1911_CR13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0145721708323100","volume":"34","author":"Farrell","year":"2008","unstructured":"Farrell JB, Deshmukh A, Baghaie AA (2008) Low testosterone and the association with type 2 diabetes. Diabetes Educ 34: 799\u2013806","journal-title":"Diabetes Educ"},{"key":"1911_CR14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF03346393","volume":"31","author":"Foresta","year":"2008","unstructured":"Foresta C, Schipilliti M, Ciarleglio FA et al (2008) Male hypogonadism in cirrhosis and after liver transplantation. J Endocrinol Invest 31: 470\u2013478","journal-title":"J Endocrinol Invest"},{"key":"1911_CR15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2164\/jandrol.108.005561","volume":"29","author":"Friedrich","year":"2008","unstructured":"Friedrich N, Volzke H, Rosskopf D et al (2008) Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men. J Androl 29: 610\u2013617","journal-title":"J Androl"},{"key":"1911_CR16","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1464-410X.2008.07933.x","volume":"102","author":"Hakimian","year":"2008","unstructured":"Hakimian P, Blute M Jr, Kashanian J et al (2008) Metabolic and cardiovascular effects of androgen deprivation therapy. BJU Int 102(11): 1509\u20131514","journal-title":"BJU Int"},{"key":"1911_CR17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000152034","volume":"2","author":"Hardelin","year":"2008","unstructured":"Hardelin JP, Dod\u00e9 C (2008) The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev 2: 181\u2013193","journal-title":"Sex Dev"},{"key":"1911_CR18","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1517\/14656566.6.10.1751","volume":"6","author":"Harle","year":"2005","unstructured":"Harle L, Basaria S, Dobs AS (2005) Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism. Expert Opin Pharmacother 6: 1751\u20131759","journal-title":"Expert Opin Pharmacother"},{"key":"1911_CR19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11934-008-0085-1","volume":"9","author":"Holyoak","year":"2008","unstructured":"Holyoak JD, Crawford ED, Meacham RB (2008) Testosterone and the prostate: implications for the treatment of hypogonadal men. Curr Urol Rep 9: 500\u2013505","journal-title":"Curr Urol Rep"},{"key":"1911_CR20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s001050050341","volume":"46","author":"H\u00f6lzle","year":"1995","unstructured":"H\u00f6lzle E, Jansen T, Plewig G (1995) Morbihan disease\u2013chronic persistent erythema and edema of the face. Hautarzt 46: 796\u2013798","journal-title":"Hautarzt"},{"key":"1911_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3132\/dvdr.2008.022","volume":"5","author":"Kapoor","year":"2008","unstructured":"Kapoor D, Channer KS, Jones TH (2008) Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes. Diab Vasc Dis Res 5: 135\u2013137","journal-title":"Diab Vasc Dis Res"},{"key":"1911_CR22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/13685530802290438","volume":"11","author":"Karazindiyanoglu","year":"2008","unstructured":"Karazindiyanoglu S, Cayan S (2008) The effect of testosterone therapy on lower urinary tract symptoms\/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male 11: 146\u2013149","journal-title":"Aging Male"},{"key":"1911_CR23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00345-003-0372-x","volume":"21","author":"Kohn","year":"2003","unstructured":"Kohn FM, Schill WB (2003) A new oral testosterone undecanoate formulation. World J Urol 21: 311\u2013315","journal-title":"World J Urol"},{"key":"1911_CR24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1368-5031.2004.00383.x","volume":"58","author":"Korbonits","year":"2004","unstructured":"Korbonits M, Kipnes M, Grossman AB (2004) Striant SR: a novel, effective and convenient testosterone therapy for male hypogonadism. Int J Clin Pract 58: 1073\u20131080","journal-title":"Int J Clin Pract"},{"key":"1911_CR25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1210\/jc.2005-1326","volume":"91","author":"Kupelian","year":"2006","unstructured":"Kupelian V, Page ST, Araujo AB et al (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91: 843\u2013850","journal-title":"J Clin Endocrinol Metab"},{"key":"1911_CR26","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1743-6109.2007.00531.x","volume":"4","author":"Maggi","year":"2007","unstructured":"Maggi M, Schulman C, Quinton R et al (2007) The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. J Sex Med 4: 1056\u20131069","journal-title":"J Sex Med"},{"key":"1911_CR27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1743-6109.2005.20232.x","volume":"2","author":"Mazer","year":"2005","unstructured":"Mazer N, Fisher D, Fischer J et al (2005) Transfer of transdermally applied testosterone to clothing: a comparison of a testosterone patch versus a testosterone gel. J Sex Med 2: 227\u2013234","journal-title":"J Sex Med"},{"key":"1911_CR28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3810\/pgm.2008.09.1914","volume":"120","author":"Miner","year":"2008","unstructured":"Miner M, Canty DJ, Shabsigh R (2008) Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices. Postgrad Med 120: 130\u2013153","journal-title":"Postgrad Med"},{"key":"1911_CR29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1742-1241.2006.00992.x","volume":"60","author":"Mulligan","year":"2006","unstructured":"Mulligan T, Frick MF, Zuraw QC et al (2006) Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 60: 762\u2013769","journal-title":"Int J Clin Pract"},{"key":"1911_CR30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/13685530801954026","volume":"11","author":"Pradidarcheep","year":"2008","unstructured":"Pradidarcheep W (2008) Lower urinary tract symptoms and its potential relation with late-onset hypogonadism. Aging Male 11: 51\u201355","journal-title":"Aging Male"},{"key":"1911_CR31","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.apmr.2008.05.001","volume":"89","author":"Schneider","year":"2008","unstructured":"Schneider J (2008) Hypogonadism in men treated with chronic opioids. Arch Phys Med Rehabil 89: 1414","journal-title":"Arch Phys Med Rehabil"},{"key":"1911_CR32","first-page":"2008","volume":"Res","author":"Shabsigh","year":"2008","unstructured":"Shabsigh R, Crawford ED, Nehra A, Slawin KM (2008) Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. Int J Impot Res: 2008 Jul 17 [Epub ahead of print]","journal-title":"Int J Impot"},{"key":"1911_CR33","first-page":"4500","volume":"85","author":"Swerdloff","year":"2000","unstructured":"Swerdloff RS, Wang C, Cunningham G et al (2000) Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 85: 4500\u20134510","journal-title":"J Clin Endocrinol Metab"},{"key":"1911_CR34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ncpuro1167","volume":"5","author":"Tostain","year":"2008","unstructured":"Tostain JL, Blanc F (2008) Testosterone deficiency: a common, unrecognized syndrome. Nat Clin Pract Urol 5: 388\u2013396","journal-title":"Nat Clin Pract Urol"},{"key":"1911_CR35","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00120-008-1804-4","volume":"47","author":"Tuttelmann","year":"2008","unstructured":"Tuttelmann F, Gromoll J, Kliesch S (2008) Genetics of male infertility. Urologe A 47(12): 1561\u20131567","journal-title":"Urologe A"},{"key":"1911_CR36","first-page":"2008","volume":"Androl","author":"Wang","year":"2008","unstructured":"Wang C, Nieschlag E, Swerdloff R et al (2008) Investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Androl: 2008 Sep 16 [Epub ahead of print]","journal-title":"Int J"},{"key":"1911_CR37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/EJE-08-0601","volume":"159","author":"Wang","year":"2008","unstructured":"Wang C, Nieschlag E, Swerdloff R et al (2008) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 159: 507\u2013514","journal-title":"Eur J Endocrinol"},{"key":"1911_CR38","first-page":"2008","volume":"Res","author":"Wang","year":"2008","unstructured":"Wang C, Nieschlag E, Swerdloff R et al (2008) ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res: 2008 Oct 16 [Epub ahead of print]","journal-title":"Int J Impot"},{"key":"1911_CR39","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.beem.2008.06.002","volume":"22","author":"Wiren","year":"2008","unstructured":"Wiren S, Stattin P (2008) Androgens and prostate cancer risk. Best Pract Res Clin Endocrinol Metab 22: 601\u2013613","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1911_CR40","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1210\/jc.2006-0401","volume":"91","author":"Zitzmann","year":"2006","unstructured":"Zitzmann M, Faber S, Nieschlag E (2006) Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91: 4335\u20134343","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1911-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-008-1911-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1911-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:58:54Z","timestamp":1558594734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-008-1911-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1007\/s00120-008-1911-2","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}